Daniel Wang

10.1k citations
63 papers · 2.4k · 2 hit papers · h-index 22

Impact in

  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • Immune Response and Inflammation
    • T-cell and B-cell Immunology
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Colorectal Cancer Treatments and Studies

Papers in

    • Cancer Immunotherapy and Biomarkers 18
    • CAR-T cell therapy research 7
    • Colorectal Cancer Treatments and Studies 4
    • Immunotherapy and Immune Responses 9
    • Immune Cell Function and Interaction 5
    • Immune cells in cancer 4

Daniel Wang

58 papers receiving 2.3k citations

Daniel Wang's Hit Papers

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme 2014 · 432 citations
4320+7+14Years since publication200400600

Peers

Daniel Wang
Comparison fields: 5 of 124
  • Immunology 780
  • Oncology 743
  • Physiology 81
  • Epidemiology 473
  • Software 45
Replace Fan Xia with:
Fan Xia China
Hai‐Ning Chen China
Akanksha Verma United States
Wenbin Qian China
Sabina Berezowska Switzerland
Dongfang Liu United States
Yong Cai China
Tadakazu Kondo Japan
Julie Klein France
Weiguo Hu China
Daniel Wang relative to Fan Xia China Fan Xia's profile →
Citations per field
00.5×9.6×
Fan Xia · 1×
Citations per year

Countries citing papers authored by Daniel Wang

Since Specialization
Citations

This map shows the geographic impact of Daniel Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wang more than expected).

Fields of papers citing papers by Daniel Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wang. The network helps show where Daniel Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Wang Line = papers co-authored together Daniel Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell Function
Hit paper breakdown →
2005637
2
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
Hit paper breakdown →
2014432
3 2017167
4 2017118
5 200687
6 201884
7 201957
8 201755
9 202052
10 201841
11 201938
12 201736
13 201834
14 200633
15 202032
16 201429
17 202228
18 202124
19 200223
20 201923

About Daniel Wang

Daniel Wang is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 63 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Immune cells in cancer (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Respiratory viral infections research (3 papers). The work is most often cited by research in Immunology (780 citations), Oncology (743 citations), Physiology (81 citations), Epidemiology (473 citations) and Software (45 citations). Daniel Wang has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Douglas B. Johnson, Yanchun Li, Tihui Fu, Weiyi Peng, Helen Y. Wang, Rongfu Wang, Yukiko Kiniwa, Guangyong Peng, Kui Shin Voo and Zhong Guo. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Blood, The Journal of Immunology, Cancer Research and Cancer Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact